Coronary imaging characteristics and risk factors in patients with type 2 diabetes mellitus with coronary heart disease complication

Table 1 General data and laboratory test indicators, mean ± SD/n (%)

Characteristic	Control group (n = 48)	Observation group (n = 55)	χ2/t value	P value
Age (years)	61.21 ± 10.21	65.20 ± 9.96	2.006	0.048
Sex			0.173	0.677
Male	29 (60.42)	31 (56.36)
Female	19 (39.58)	24 (43.64)
History of smoking and drinking			0.109	0.741
With	26 (54.17)	28 (50.91)
Without	22 (45.83)	27 (49.09)
Family history of coronary heart disease			2.746	0.098
With	15 (31.25)	26 (47.27)
Without	33 (68.75)	29 (52.73)
BMI (mmol/L)	23.15 ± 2.69	24.09 ± 2.74	1.752	0.083
FBG (mmol/L)	10.58 ± 2.87	14.72 ± 3.92	6.038	0.000
TG (mmol/L)	2.09 ± 0.79	2.41 ± 0.82	2.015	0.047
TC (mmol/L)	5.82 ± 1.08	6.18 ± 1.12	1.655	0.101
HDL-C (mmol/L)	1.13 ± 0.52	1.24 ± 0.48	1.116	0.267
LDL-C (mmol/L)	2.98 ± 0.57	3.22 ± 0.63	2.017	0.046
SCr (μmol/L)	62.77 ± 10.87	63.76 ± 11.25	0.453	0.652
BUN (mmol/L)	5.49 ± 1.14	6.05 ± 1.58	2.035	0.044
ALT (U/L)	25.88 ± 5.92	27.71 ± 6.31	1.511	0.134
AST (U/L)	24.72 ± 6.74	25.41 ± 6.17	0.542	0.589

BMI: Body mass index; FBG: Fasting blood glucose; TG: Triglyceride; TC: Total cholesterol; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; SCr: Serum creatinine; BUN: Blood urea nitrogen; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.